https://www.ajmc.com/view/patient-reported-outcomes-favor-concizumab-prophylaxis-in-hemophilia-a-or-b
Analysis of the phase 3 explorer7 (NCT04083781) study indicates a preference for concizumab prophylaxis over no prophylaxis in patients with hemophilia A or B...
patient reported outcomesfavorconcizumabprophylaxishemophilia